HIT Consultant

MARCH 30, 2023

What You Should Know: – Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces today the launch of its first therapy selection test, the My Phenome Hungry Gut test.

Biotechnology 96

Biotechnology 96

HIT Consultant

APRIL 6, 2023

a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer and FDA approval to commence a clinical trial of the Biostage Esophageal Implant raises $6M from new and existing investors in a private placement of its shares of common stock. What You Should Know: Biostage, Inc.,

Biotechnology 98

Biotechnology Life Sciences 98

Bill Of Health

OCTOBER 17, 2023

It seems, in the near term, that the “who” would probably be a venture-backed biotechnology company — a corporate actor. Open questions abound for cell-based testing services, but perhaps the first among them would be: who would offer them?

Biotechnology 110

Biotechnology Regulations Medical Technology 110

HIT Consultant

DECEMBER 7, 2023

What You Should Know: Insilico Medicine (“Insilico”) , a generative artificial intelligence (AI)-driven clinical-stage biotechnology company, today announced that the company has initiated the first-in-human study for ISM5411, a potentially first-in-class PHD inhibitor for the treatment of inflammatory bowel disease (IBD).

Biotechnology 98

Biotechnology Regulations 98

HIT Consultant

SEPTEMBER 29, 2023

What You Should Know: – Phenomix Sciences , a precision medicine biotechnology company that brings data-driven precision medicine to obesity treatment, announced it has been awarded the first patent related to its obesity phenotyping technology. – The patent (No.

Biotechnology 105

Biotechnology Life Sciences 105

HIT Consultant

OCTOBER 14, 2022

Obatala Sciences, a New Orleans biotechnology company, was founded in 2017 to enable diversity in clinical research and speed up the development of better therapies for diseases like obesity, diabetes, and cancer, and advance research in tissue engineering and regenerative medicine. Trivia Frazier, Ph.D.,

Biotechnology 98

Biotechnology Pharmaceuticals Healthcare Innovation Prevention 98

HIT Consultant

NOVEMBER 18, 2021

Benchling’s growth is fueled by the rapid rise of biotechnology , one of the world’s fastest-growing industries. As biotechnology companies come under increased pressure to deliver breakthroughs, they are turning to modern software to digitize all their scientific processes and centralize their data. Recent Traction/Milestones.

Biotechnology 97

Biotechnology Life Sciences Pharmaceuticals Accountability 97

HIT Consultant

NOVEMBER 2, 2022

Dr. Squinto joins from OrbiMed Advisors and brings more than 30 years of experience in the biotechnology company building and investing space, having co-founded and built numerous biotechnology companies including Alexion Pharmaceuticals and acting as a key scientific founder of Regeneron Pharmaceuticals. Joining Dr.

Life Sciences 98

Life Sciences Biotechnology Pharmaceuticals Healthcare 98

Bill Of Health

JUNE 16, 2023

Panelists discussed these topics during a recent webinar hosted by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. By Minsoo Kwon The legalization of cannabis has raised ethical, regulatory, and scientific questions. This article highlights key points made during the conversation.

Biotechnology 104

Biotechnology Regulations Hospitals 104

Bill Of Health

SEPTEMBER 13, 2023

These five students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from Harvard Law School. At the law school, Adithi is interested in examining how emerging biotechnologies in regenerative medicine intersect with patient privacy and other ownership rights.

Biotechnology 57

Biotechnology Medical Technology Prevention Healthcare 57

Healthcare ECONOMIST

APRIL 8, 2024

If the EMA evaluates a pharmaceutical and grants it marketing authorization, this determination is binding all all European Union member states. cell and gene-therapy) also in 2008.

Pharmaceuticals 75

Pharmaceuticals Biotechnology Regulations 75

Bill Of Health

AUGUST 26, 2022

Myriad Genetics could boost investment in biotechnology R&D. Although genetic and other biotechnological research often begins in universities under federal funding, patents were clearly the focus of the university scientists racing to identify BRCA1 and BRCA2, as well as a gene relevant to Alzheimer’s.

Biotechnology 52

Biotechnology Pharmaceuticals 52

Bill Of Health

APRIL 28, 2023

The Petrie-Flom Center Student Fellowship is a competitive one-year program designed to support Harvard graduate students interested in pursuing independent scholarly projects related to health law policy, biotechnology, and bioethics.

Biotechnology 51

Biotechnology Law Firms 51

HIT Consultant

OCTOBER 30, 2023

United Therapeutics is a biotechnology company with six FDA-approved therapies to address rare, life-threatening conditions, and a pipeline that includes four ongoing registration-phase studies. Miromatrix Background Miromatrix is a life sciences company focused on the development of bioengineered organs composed of human cells.

Life Sciences 52

Life Sciences Biotechnology Healthcare 52

HIStalk

NOVEMBER 6, 2022

Top News Roche, the world’s largest biotechnology company, unifies its.

Biotechnology 64

Biotechnology 64

HIT Consultant

JANUARY 3, 2022

HCS), a company focused on helping patients adhere to and benefit from pharmaceutical and biotechnology products. CareMetx, LLC, a leading technology-enabled hub services company focused on improving patient access to specialty medications, announced today the acquisition of Human Care Systems, Inc.

Biotechnology 98

Biotechnology Pharmaceuticals Healthcare 98

HIT Consultant

OCTOBER 7, 2021

The firm is continuing to add new pharmaceutical and biotechnology companies to its client base, in new therapeutic areas, and has continued to expand with the addition of over 100 new employees so far in 2021.

Biotechnology 97

Biotechnology Pharmaceuticals Life Sciences 97

Bill Of Health

DECEMBER 8, 2023

It did not introduce unprecedented enablement principles, and, in practice, biotechnology genus claims, including antibody claims, were already limited. The other possibility is that Amgen will only affect the patentability of antibodies, which long received more lenient treatment than other biotechnologies.

Biotechnology 52

Biotechnology Life Sciences Pharmaceuticals Regulations 52

HIT Consultant

SEPTEMBER 21, 2022

Founded in 2017, Naveris is a privately held biotechnology company with facilities in Massachusetts and North Carolina. The company has also partnered with biotechnology companies developing immunotherapies for HPV-related cancers. Using DNA Fragmentomics Technology to Detect Cancer Earlier.

Biotechnology 52

Biotechnology Life Sciences 52

Healthcare It News

SEPTEMBER 9, 2022

It is funded through the state's Australian Medtech Manufacturing Centre and Biotechnology Fund and is being delivered by digital health accelerator ANDHealth. Programme to support clinical entrepreneurs launched in WA. A new programme to support clinical entrepreneurs has been launched in Western Australia.

Biotechnology 162

Biotechnology Doctors Hospitals Healthcare 162

HIT Consultant

MARCH 30, 2022

VivoSense interprets and contextualizes data gathered directly from the patient and makes it available to clinical researchers in pharma and biotechnology. These include physical activity, sleep, temperature, blood glucose levels, respiration, and cardiac function.

Life Sciences 98

Life Sciences Biotechnology 98

Bill Of Health

APRIL 19, 2023

Panelists discussed these topics during a recent webinar hosted by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. This article highlights key points made during the conversation. First, BJ Casey , Christina L.

Biotechnology 57

Biotechnology Rehabilitation Prevention Regulations 57

HIT Consultant

OCTOBER 26, 2023

What You Should Know: – Georgiamune , a privately held, clinical stage biotechnology company, and Verily , an Alphabet precision health technology company forms a strategic partnership to advance novel therapeutics for patients with cancer.

Biotechnology 52

Biotechnology Health Technology Integration Life Sciences 52

HIT Consultant

OCTOBER 20, 2023

What You Should Know: Gero , a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding round positions Gero to continue internal drug development programs, grow its scientific team to boost platform technology development, and expand its US presence.

Biotechnology 52

Biotechnology Pharmaceuticals Health Data Life Sciences 52

HIT Consultant

AUGUST 30, 2021

What You Should Know: Fresenius Medical Care (FMC) today announced its plans to invest an additional $25 million in clinical-stage biotechnology platform company Humacyte following the extension of its collaboration in June. Fresenius Medical Care acquired a stake in Humacyte in 2018 for $150M as part of a strategic partnership.

Biotechnology 52

Biotechnology Life Sciences 52

HIT Consultant

SEPTEMBER 12, 2022

Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. In addition, the Sanderson Study will build the necessary infrastructure to bridge the gap between clinical research and day-to-day clinical impact.

Biotechnology 98

Biotechnology Prevention Health Data Hospitals 98

HIT Consultant

AUGUST 5, 2022

– The larger transactions in the quarter were, once again, transactions occurring in the Pharmaceutical and Biotechnology subsectors. . – Overall transaction value of deals announced and/or closed in Q2 2022 was $26 billion versus $31 billion in Q2 2021 and $65 billion in Q4 2021.

Life Sciences 98

Life Sciences Telemedicine Healthcare Biotechnology 98

Bill Of Health

MARCH 1, 2022

Potentially the most relevant case for teaching students about IP is that they may want to leverage this knowledge to turn their laboratory discoveries into new biotechnology companies. One of the most important factors for funders of biotechnology companies is the IP portfolio the company might have or be able to license.

Law Firms 92

Law Firms Biotechnology Doctors 92

HIT Consultant

OCTOBER 12, 2022

Pleno is based in San Diego’s Sorrento Mesa innovation hub proximate to a robust talent pool of experienced scientists, telecommunication engineers, and biotechnology innovators. The company currently employs 24 full-time employees and plans to continue to grow its team rapidly in the coming months.

Biotechnology 52

Biotechnology Life Sciences 52

HIT Consultant

JANUARY 14, 2022

Verana Health is the exclusive data partner of the American Academy of Ophthalmology, American Urological Association, and American Academy of Neurology and collaborates with multinational pharmaceutical companies as well as emerging biotechnology and biopharmaceutical companies. Expansion Plans.

Life Sciences 98

Life Sciences Biotechnology Pharmaceuticals Population Health 98

Cloud Blogs

MAY 18, 2021

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.

Biotechnology 98

Biotechnology Life Sciences Healthcare Innovation Healthcare 98

HIT Consultant

MARCH 13, 2023

What You Should Know: – Pfizer announced it will acquire biotechnology company Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion. The proposed combination enhances Pfizer’s position as a leading company in Oncology.

Biotechnology 52

Biotechnology Life Sciences Healthcare 52

HIT Consultant

JUNE 30, 2022

Architect: Early-stage asset acquisitions—often with a biotechnology platform (bio-platform)—that enable companies to expand their pipeline across therapeutic areas. Combine biotechnology platforms (bio-platforms) and capabilities to create value.

Life Sciences 52

Life Sciences Biotechnology Integration 52

HIT Consultant

JULY 19, 2023

In Mexico, Omica.bio is leading a revolution in ethical biotechnology. This is vital in sustaining this initiative and ensuring people in Brazil can benefit from the latest drugs and scientific discoveries.”

Biotechnology 52

Biotechnology Life Sciences Population Health Health Data 52

HIT Consultant

FEBRUARY 27, 2024

As the CEO of Verix for the past 15 years, it has been his mission to help pharmaceutical and biotechnology companies use data to provide better, more comprehensive care to millions of patients worldwide. He specializes in building and expanding early-stage companies with a customer-centric approach.

Pharmaceuticals 98

Pharmaceuticals Biotechnology Life Sciences 98

HIT Consultant

SEPTEMBER 20, 2022

What You Should Know: – Pretzel Therapeutics, a biotechnology company harnessing the intricacies of mitochondrial biology to develop groundbreaking therapies, launched today with $72.5M in Series A financing to pioneer novel therapies to modulate mitochondrial function.

Quality Control 52

Quality Control Biotechnology Life Sciences 52

HIT Consultant

JANUARY 11, 2022

What You Should Know: – PostEra , a biotechnology company specializing in machine learning for preclinical drug discovery, today announced $24M in equity financing to accelerate medicinal chemistry and bring new cures to patients.

Biotechnology 52

Biotechnology Integration Life Sciences 52